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Background
Osteoarthritis (OA) is a ubiquitous degenerative disease that generates
signi"cant global disability and socio-economic burden, forcing more
than 8.75 million people aged 45 or over to seek treatment in the
UK/annum. (1) OA predominantly a!ects the lower limbs, however
prevalence in the knee is 10-fold higher than in the ankle, with notably
di!ering aetiology between the joints. Knee OA is characteristically a
‘wear-and-tear’ primary arthritis; in contrast, 90% of ankle OA cases are
preceded by trauma-induced joint instability. (2) Hence, ankle cartilage
is thought to be relatively protected from the catabolic phenotype that
constitutes primary OA pathogenesis. Such protection is likely mediated
through biochemical and biomechanical variations including lower 
concentrations of matrix metalloproteinases (MMPs) - cartilage degrading
enzymes, and a reduced sensitivity to pro-in#ammatory cytokines.
These include Interleukin 1ß (IL-1ß) and Tumour Necrosis Factor-
(TNF), which potentiate an OA phenotype in cartilage. (3, 4)
Prior RNA sequencing data identi"ed a potential increased expression
of the Superoxide Dismutase 1 (SOD1) gene in ankle cartilage relative
to the knee; a gene encoding an intracellular antioxidant enzyme that 
reduces oxidative stress. Oxidative stress is elevated in OA cartilage and
is associated with inducing chondrocyte dysfunction, partly through 
upregulation of OA-linked pro-in#ammatory cytokines. (5) Following
receipt of the Wolfson Intercalated Award (Royal College of Physicians),
I used an in vitro model to investigate whether this relative increase in
SOD1 was partly responsible for conferring protection against 
cytokine-induced chondrocyte catabolism.
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Methods
Immortalised ATDC5 mouse teratocarcinoma cells were utilised as
a chondrocyte source. Cells were seeded within media suspension
(100,000/well of a 48-well plate) and subsequently treated (n=6)
with 0.31U or 0.63U of bovine erythrocyte SOD1 (25U/mg and
50U/mg of cellular protein respectively). This represented the 
physiological concentrations of SOD1 reported for knee and ankle
articular cartilage in the literature (6). SOD1 treatment occurred in
the presence or absence of 5ng/ml IL-1 and 10ng/ml Oncostatin
M treatment - used to mimic the pro-in#ammatory catabolic 
response observed in OA; untreated cells served as controls. Cells
were treated for 1, 2, 3 or 7 days, with media and cell lysates
analysed for cytotoxicity, as well as markers of in#ammation (nitric
oxide (NO), prostaglandin E2 (PGE2)) and chondrocyte metabolism
(sulphated glycosaminoglycan (sGAG), type II collagen).
Results
Following normalisation to ATDC5 protein content, as a marker of
cell metabolic activity, it was observed that both 0.31U (p≤0.001)
and 0.63U (p≤0.01) of SOD1 treatment blunted cytokine-induced
NO synthesis at day 7. Furthermore, 0.31U of SOD1 treatment
signi"cantly lowered cytokine-induced PGE2 media content by 
day 7 (p≤0.05). Surprisingly, sGAG content was not a!ected by 
cytokine or SOD1 treatment.
Discussion
SOD1 treatment signi"cantly reduced cytokine-induced upregulation
of NO and PGE2 in an ATDC5 chondrocyte-like cell line. Limiting
the synthesis of pro-in#ammatory molecules, such as NO and
PGE2, potentially reduces the cartilaginous tissue loss characteristic
of OA, through decreasing MMP expression and the mitochondrial
dysfunction that initiates a chondrocyte apoptotic response. (7) NO
and PGE2 additionally suppress neosynthesis of type II collagen and
proteoglycans; (8) therefore, the demonstrated e!ects of SOD1 may
facilitate cartilage regeneration plausibly perturbing OA pathogenesis.
Restricting NO and PGE2 production also disrupts positive 
feedback-mediated upregulation of pro-in#ammatory cytokines,
de"ning an additional mechanism by which SOD1 treatment may
reduce joint in#ammation. (8) With a potential protective role for
SOD1 against a catabolic OA-like phenotype identi"ed, it can be
hypothesised that its elevated expression in ankle chondrocytes 
relative to knee may be partially responsible for the relative 
susceptibilities of each joint to osteoarthritic degeneration. Never-
theless, future studies are necessary to determine whether these
SOD1-mediated reductions in catabolic activities correlate with
measurable decreases in human cartilage matrix degradation.
Furthermore, our study may suggest applications for exogenous
SOD1 in OA treatment, through attempting to recapitulate innate
ankle SOD1 concentrations within OA a(icted joints. This concept
is supported by literary evidence for the bene"cial e!ects of 
Orgotein, a bovine non-speci"c SOD intra-articular injection,
prior to its discontinuation due to adverse e!ects. (9) Tempol, a
SOD mimetic, exhibits a more controlled attenuation of arthritic
in#ammation due to its biological membrane permeability but has
further noxious systemic e!ects. (10) Therefore, further research
into de"ning mechanisms of SOD1 endocytosis and its extracellular
functionality may facilitate a future for recombinant SOD1 as a
more e!ective treatment for OA.
Lessons Learnt
This research project introduced skills such as statistical analysis, 
tissue culture, and laboratory techniques including pipetting,
ELISAs and Western Blotting. With no prior experience of the
techniques employed, I found the project a challenging and initially
daunting experience, and o%en frustrating when meticulous time-
consuming investigations revealed unusable or anomalous data.
This included the data for 3 days of SOD1 treatment, yielding non-
signi"cant results and a low metabolic activity that implied 
compromised cell viability. This highlighted the uncertainty of 
research, the susceptibility of delicate techniques to error, and the
importance of subsequent perseverance and investigation into 
possible explanations. Learning these challenging techniques and
how to systematically approach and resolve problematic situations
are skills I will now directly apply to similar future situations in
medicine.
Moreover, conducting pioneering research was initially disconcerting,
with no information to cross-reference "ndings. However, analysing
novel results taught me a versatility with processing literature 
evidence, utilising current knowledge in the "eld to explain my
own results. Upon presentation of my work, academic questioning
surrounding the methods I employed made me aware of the 
importance of not only understanding what you are doing, but also
why. Whether designing an experiment, explaining novel results or
treating patients, I now have an increased appreciation for the 
importance of literature-based evidence and its skillful handling to
guide decision-making. Not only are evidence-based decisions 
important, but so is an awareness of methodological reasoning and a
pliability of your decisions to be in line with the latest evidence.
In conclusion, this project emphasised how pivotal research is to
identify biological targets to optimise the treatment of patients. This
philosophy has inspired me to integrate research into my future 
career, as I believe it paramount that doctors are involved in the 
furthering of medicinal knowledge.
36
References
1. Versus Arthritis. The state of MSK health report 2018. 2018 
[accessed 27 July 2019]. 
Available from: 
https://www.arthritisresearchuk.org/arthritis-information/data-
and-statistics/state-of-musculoskeletal-health/what-is-the-scale-of-
the-problem.aspx.
2. Valderrabano V, Horisberger M, Russell I, Dougall H, 
Hintermann B. Etiology of Ankle Osteoarthritis. Clinical 
Orthopaedics and Related Research. 2009;467:1800.
https://doi.org/10.1007/s11999-008-0543-6 
PMid:18830791 PMCid:PMC2690733
3. Eger W, Schumacher B, Mollenhauer J, Kuettner K, Cole A.
Human knee and ankle cartilage explants: catabolic di!erences.
Journal of Orthopaedic Research. 2002;20:526-34.
https://doi.org/10.1016/S0736-0266(01)00125-5
4. Hendren L, Beeson P. A review of the di!erences between 
normal and osteoarthritis articular cartilage in human knee and
ankle joints. The Foot. 2009;19:171-76.
https://doi.org/10.1016/j.foot.2009.03.003 
PMid:20307471
5. Scott J, Gabrielides C, Davidson R, Swingler T, Clark I, Wallis
G, et al. Superoxide dismutase down regulation in osteoarthritis
progression and end-stage disease. Annals of Rheumatic Diseases.
2010;69:1502-1510.
https://doi.org/10.1136/ard.2009.119966 
PMid:20511611 PMCid:PMC3789136
6. Koikes M, Nojiri H, Kanazawa H, Yamaguchi H, Miyagawa K,
Nagura N, et al. Superoxide dismutase activity is signi"cantly lower
in end-stage osteoarthritic cartilage than non-osteoarthritic 
cartilage. PLoS One. 2018 [accessed 17 Sept 2019]. 
Available from: 
https://journals.plos.org/plosone/article?id=10.1371/
journal.pone.0203944.
https://doi.org/10.1371/journal.pone.0203944 
PMid:30222787 PMCid:PMC6141073
7. Mathiessen A, Conaghan P. Synovitis in osteoarthritis: current
understanding with therapeutic implications. Arthritis Research &
Therapy. 2017;19:18.
https://doi.org/10.1186/s13075-017-1229-9 
PMid:28148295 PMCid:PMC5289060
8. Mastbergen S, Bijlsma J, Lafeber F. Synthesis and release of
human cartilage matrix proteoglycans are di!erently regulated by
nitric oxide and prostaglandin-E2. Annals of the Rheumatic 
Diseases. 2008;67:52-58.
https://doi.org/10.1136/ard.2006.065946 
PMid:17485421
9. Afonso V, Champy R, Mitrovic D, Collin P, Lomri A. Reactive
oxygen species and superoxide dismutases: Role in joint diseases.
Joint Bone Spine. 2007;74:324-329.
https://doi.org/10.1016/j.jbspin.2007.02.002 
PMid:17590367
10. Cuzzocrea S, McDonald M, Mota-Filipe H, Mazzon E,
Costantino G, Britti D, et al. Bene"cial e!ects of tempol, a 
membrane-permeable radical scavenger, in a rodent model of 
collagen-induced arthritis. Arthritis and Rheumatism.
2000;43:320-328.
https://doi.org/10.1002/1529-0131(200002)43:2<320::AID-
ANR11>3.0.CO;2-9
37The Bri!sh Student Doctor
Volume 3, No. 3 (2019)
bsdj.org.uk
@thebsdj
/thebsdj
@thebsdj
bsdj.org.uk
The Bri!sh Student Doctor is an open access journal, which
means that all content is available without charge to the user
or his/her ins!tu!on. You are allowed to read, download, copy,
distribute, print, search, or link to the full texts of the ar!cles
in this journal without asking prior permission from either the
publisher or the author.
This journal is licensed under a Crea!ve Commons A"ribu!on­
NonCommercial­NoDeriva!ves 4.0 Interna!onal License. The
copyright of all ar!cles belongs to The Bri!sh Student Doctor,
and a cita!on should be made when any ar!cle is quoted, used
or referred to in another work.
The Bri!sh Student Doctor is an imprint of Cardiff University
Press, an innova!ve open­access publisher of academic
research, where ‘open­access’ means free for both readers and
writers.
cardiffuniversitypress.org
Journal DOI
10.18573/issn.2514­3174
Issue DOI
10.18573/bsdj.v3i3
